Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$62.5M
-14.6% from 2023
Prescriptions
6,035
$10,353.16 per claim
Patients
745
872 prescribers
Total spending, 2024
$62.5M
$83,795.11 per patient
Medicare prescription drug plans paid $62.5M for Gleevec in 2024, for 6,035 prescriptions and refills to 745 patients (down 14.6% from 2023). The average cost per claim was $10,353.16.
New York had the highest Medicare cost for Gleevec in 2024: $8.7M for 786 claims, followed by Florida ($5.9M).
Margaret Von-Mehren, hematopoietic cell transplantation and cellular therapy in Philadelphia, PA, had the highest Medicare cost for Gleevec in 2024: 57 claims costing $615K.
Gleevec is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Margaret Von-Mehren Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 57 | Under 11 | $615K |
| Michael C Heinrich Portland, OR | Hematology-Oncology | 39 | Under 11 | $446K |
| Morgan S Mount |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,171 | 8,514 | 1,010 | $90.8M |
| 2023 | 1,005 | 6,802 | 863 | $73.2M |
| 2024 | 872 | 6,035 | 745 | $62.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 39 |
| Under 11 |
| $360K |
| Marisa J Hine New York, NY | Nurse Practitioner | 18 | Under 11 | $358K |
| Ping CHI New York, NY | Medical Oncology | 32 | Under 11 | $316K |
| Bashar S Alasad Oklahoma City, OK | Medical Oncology | 14 | Under 11 | $281K |
| Michael B Wax Berkeley Heights, NJ | Medical Oncology | 19 | Under 11 | $267K |
| Aji Mathew Houston, TX | Nurse Practitioner | 24 | Under 11 | $264K |
| Mrinal M Gounder New York, NY | Medical Oncology | 25 | Under 11 | $263K |
| Arun S Singh Santa Monica, CA | Hematology-Oncology | 24 | Under 11 | $254K |
| Jennifer T Andres Scottsdale, AZ | Nurse Practitioner | 14 | Under 11 | $248K |
| Noman Rafique Massillon, OH | Hematology-Oncology | 24 | Under 11 | $242K |
| Anthony P Conley Houston, TX | Medical Oncology | 18 | Under 11 | $240K |
| Elquis M Castillo Gadsden, AL | Medical Oncology | 18 | Under 11 | $234K |
| Rashmi Chugh Ann Arbor, MI | Medical Oncology | 23 | Under 11 | $232K |
| Patrick J Mansky Frederick, MD | Medical Oncology | 12 | Under 11 | $227K |
| Jess F Armor Oklahoma City, OK | Hematology-Oncology | 17 | Under 11 | $226K |
| Farn Chan Woodbridge, VA | Hematology-Oncology | 13 | Under 11 | $225K |
| Sanjay P Oommen Fort Worth, TX | Hematology-Oncology | 14 | Under 11 | $224K |
| Susanna Hong Middletown, CT | Hematology-Oncology | 28 | Under 11 | $220K |
| Elizabeth D Weiland Charleston, SC | Nurse Practitioner | 34 | Under 11 | $219K |
| Abraham B Schwarzberg Palm Springs, FL | Medical Oncology | 11 | Under 11 | $219K |
| Bernadette Cuello New York, NY | Nurse Practitioner | 17 | Under 11 | $216K |
| William D Tap New York, NY | Hematology-Oncology | 20 | Under 11 | $214K |
| Gazala N Khan Ann Arbor, MI | Hematology-Oncology | 11 | Under 11 | $214K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 6,041 | $62.5M |